205 related articles for article (PubMed ID: 29534829)
1. Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy.
Gabani P; Robinson CG; Ansstas G; Johanns TM; Huang J
Radiother Oncol; 2018 May; 127(2):310-317. PubMed ID: 29534829
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
3. Melanoma brain metastases: is it time to eliminate radiotherapy?
White RJ; Abel S; Horne ZD; Lee J; Edington H; Greenberg L; Younes H; Hilton C; Wegner RE
J Neurooncol; 2020 Aug; 149(1):27-33. PubMed ID: 32556863
[TBL] [Abstract][Full Text] [Related]
4. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
[TBL] [Abstract][Full Text] [Related]
5. Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer.
Chodavadia PA; Jacobs CD; Wang F; Salama JK; Kelsey CR; Clarke JM; Ready NE; Torok JA
Transl Lung Cancer Res; 2021 Jan; 10(1):261-273. PubMed ID: 33569310
[TBL] [Abstract][Full Text] [Related]
6. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Am J Hematol; 2016 May; 91(5):476-80. PubMed ID: 26852276
[TBL] [Abstract][Full Text] [Related]
7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database.
Bates JE; Morris CG; Milano MT; Yeung AR; Hoppe BS
Radiother Oncol; 2019 Sep; 138():75-79. PubMed ID: 31252297
[TBL] [Abstract][Full Text] [Related]
9. The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.
Wang SJ; Jhawar SR; Rivera-Nunez Z; Silk AW; Byun J; Miller E; Blakaj D; Parikh RR; Weiner J; Goyal S
Cureus; 2020 Jun; 12(6):e8767. PubMed ID: 32714704
[TBL] [Abstract][Full Text] [Related]
10. Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
Galli G; Cavalieri S; Di Guardo L; Cimminiello C; Nichetti F; Corti F; Garcia MA; Pappalardi B; Fallai C; de Braud F; Platania M; Del Vecchio M
Oncol Res Treat; 2019; 42(4):186-194. PubMed ID: 30836373
[TBL] [Abstract][Full Text] [Related]
11. Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor.
Amin S; Baine MJ; Meza JL; Lin C
JAMA Netw Open; 2020 Sep; 3(9):e2015444. PubMed ID: 32902650
[TBL] [Abstract][Full Text] [Related]
12. Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After.
Woody S; Hegde A; Arastu H; Peach MS; Sharma N; Walker P; Ju AW
Front Oncol; 2022; 12():785350. PubMed ID: 35692764
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation and survival following surgical resection of sinonasal melanoma.
Ajmani GS; Liederbach E; Kyrillos A; Wang CH; Pinto JM; Bhayani MK
Am J Otolaryngol; 2017; 38(6):663-667. PubMed ID: 28877859
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
Ratnayake G; Reinwald S; Shackleton M; Moore M; Voskoboynik M; Ruben J; van Zelm MC; Yu D; Ward R; Smith R; Haydon A; Senthi S
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):150-156. PubMed ID: 32450331
[TBL] [Abstract][Full Text] [Related]
16. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Survival Outcomes With/Without Adjuvant Radiation Therapy in Desmoplastic Melanoma.
Lewis GD; Guzman AK; Haque W; McLellan BN; Teh BS
Dermatol Surg; 2021 Oct; 47(10):1333-1336. PubMed ID: 34537788
[TBL] [Abstract][Full Text] [Related]
18. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
[TBL] [Abstract][Full Text] [Related]
19. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Immunother; 2019; 42(6):228-235. PubMed ID: 30985445
[TBL] [Abstract][Full Text] [Related]
20. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
